REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackstone Loan Regulatory News (BGLF)

Share Price Information for Blackstone Loan (BGLF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.57
Bid: 0.55
Ask: 0.59
Change: 0.00 (0.00%)
Spread: 0.04 (7.273%)
Open: 0.57
High: 0.57
Low: 0.57
Prev. Close: 0.57
BGLF Live PriceLast checked at -
Blackstone/GSO Loan Financing is an Investment Trust

To provide shareholders with stable and growing income returns, and to grow the capital value of the investment portfolio by exposure to all debt tranches of CLOs (CLO Income Notes and other CLO Securities) and in Loan Warehouses.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Shareholder Consultation

17 Mar 2023 07:00

RNS Number : 2976T
Blackstone Loan Financing Limited
17 March 2023
 

 

17 March 2023

 

Blackstone Loan Financing Limited

(the "Company")

Results of Shareholder Consultation

 

On 26 January 2023, the Company announced it would undertake a shareholder consultation on potential policy amendments in light of the prevailing and persistent discount to net asset value ("NAV") at which the Company's shares trade and with a view to broadening investor interest in the Company's shares and maximising shareholder total return.  Since that announcement the Board, the Investment Adviser and/or the Company's joint financial advisers and brokers have consulted with shareholders and incorporated the view of Blackstone, which together represent 78% of the share capital of the Company. 

 

The shareholder consultation set out to cover the following topics: reinvestment/distribution of excess net income including expanding the Company's remit to enable direct primary market investment and a potential exit opportunity. During the consultations the topic of the Company's NAV valuation methodology was also discussed. This announcement covers the results of the shareholder consultation and a summary of proposals.

 

Reinvestment/Distribution of Excess Net Income

In general, the shareholders consulted were comfortable with the current approach taken to the allocation of excess net income between reinvestment, dividend distribution and share buybacks. It was however recognised that there are times when reinvestment by the Company into BCF may be unattractive but direct investment in primary market CLOs managed and controlled by the Investment Adviser may still be attractive. At present the Company is unable to make such direct investments. The Board believes such flexibility to be in the interests of shareholders and will propose a change to the Company's investment policy to allow such investment to be put forward at the time of the Company's Annual General Meeting ("AGM") expected to be held in July. Further details will be set out in the Notice of AGM.

 

Potential Exit Opportunity

The shareholder consultation discussed various potential exit opportunities. There was variation in feedback with no consensus whether such an exit opportunity should be offered. In general, there was no consensus for the creation of a run-off share class to sit alongside a continuing share class given the potential reduced liquidity of both such share classes. There was some appetite, but not consensus, for the entire fund being placed into run off.

As at 31 January 2023, 67% of the Company's assets were in CLO securities which must be held to maturity under EU retention regulations. Any run-off of the Company, in whole or part, would therefore take place over a number of years as the portfolio matures. There was concern from a number of shareholders that the slow decline of the Company's asset base over such an extended timeframe may reduce shareholder liquidity.

The Board and its advisers have evaluated shareholder feedback, considered these issues at length and sought to balance various views whilst cognisant of the evergreen nature of the Company. In summary, the Board does not currently believe that an immediate exit opportunity would be in the best interests of the Company and shareholders as a whole. The Board will continue to monitor the situation and consult with shareholders, and if there is no significant improvement in the discount the Board will consider putting forward a continuation vote alongside the AGM in 2024. In the period between now and the 2024 AGM, the Board will continue to use all tools at its disposal, principally its buyback policy, in an effort to mitigate the discount while taking into account the market environment for CLOs.

 

Valuation Methodology

At the Initial Public Offering of the Company in July 2014 the Company adopted a mark to market valuation methodology for all its assets. In the March 2016 Placing Programme prospectus the valuation methodology for CLO equity tranches was amended to that of mark to model. During the shareholder consultation a number of shareholders expressed concern that the mark to model approach, whilst reflective of the hold to maturity nature of retention assets, was not a good benchmark for assessing current market risk and therefore whether the Company's shares are trading at discount or premium to the risk of the underlying assets. The Board is considering these points and believes there is merit in adopting a mark to market valuation methodology at a time when the NAV derived from both methodologies are broadly aligned. The Company will make a further announcement at the time of any change in valuation approach.

 

The Board thanks all those shareholders it was able to consult with for their time.

 

The information contained within this announcement constitutes inside information.

The person responsible for arranging for the release of this announcement on behalf of the Company is Priya Mooroogen of BNP Paribas S.A., Jersey Branch, Company Secretary.

Enquiries:

 

Blackstone Loan Financing Limited

Charlotte Valeur, Chair

 

via BNP Paribas

BNP Paribas

 

01534 709189 / 813967

Singer Capital Markets

James Maxwell / Alaina Wong (Corporate Finance)

Alan Geeves / Sam Greatrex (Sales)

 

020 7496 3000

 

Winterflood Investment Trusts

Neil Langford (Corporate Finance)

Darren Willis (Sales)

020 3100 0000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFLRVLIDLIV
Date   Source Headline
20th Sep 20194:26 pmRNSHalf-year Report
20th Sep 20197:00 amRNSNet Asset Values and Monthly Reports
6th Sep 20195:12 pmRNSQ2 2019 Report
22nd Aug 20197:00 amRNSNet Asset Values and Monthly Reports
19th Jul 20197:00 amRNSNet Asset Values and Monthly Reports
18th Jul 20193:57 pmRNSDividend Declaration
11th Jul 20195:45 pmRNSResult of AGM
1st Jul 201911:21 amRNSTotal Voting Rights
26th Jun 201910:00 amRNSDirector Declaration
24th Jun 20197:00 amRNSNet Asset Values and Monthly Reports
6th Jun 20194:45 pmRNSTransaction in Own Shares
5th Jun 20195:17 pmRNSTransaction in Own Shares
4th Jun 201910:00 amRNSQ1 2019 Report
23rd May 20197:00 amRNSNet Asset Values and Monthly Reports
22nd May 20193:19 pmRNSNotice of AGM
7th May 20194:41 pmRNSDirector/PDMR Shareholding
30th Apr 20194:13 pmRNSAnnual Financial Report
23rd Apr 20197:00 amRNSNet Asset Values and Monthly Reports
18th Apr 20194:54 pmRNSDividend Declaration
4th Apr 201911:35 amRNSDirector Declaration
25th Mar 20195:25 pmRNSDirector Declaration
22nd Mar 20197:00 amRNSNet Asset Values and Monthly Reports
4th Mar 20193:46 pmRNSQ4 2018 Report
21st Feb 20197:00 amRNSNet Asset Values and Monthly Reports
23rd Jan 20191:58 pmRNSShare Repurchase Programme
22nd Jan 20193:15 pmRNSDividend Declaration
22nd Jan 20197:00 amRNSNet Asset Value and Publication of Monthly Report
21st Jan 20195:03 pmRNSHolding(s) in Company
16th Jan 20193:01 pmRNSHolding(s) in Company
8th Jan 20194:00 pmRNSDirectorate Change
3rd Jan 20195:16 pmRNSIssue of C Shares postponed
21st Dec 20184:43 pmRNSResults of Rollover Offer and Issue of C Shares
21st Dec 20187:00 amRNSNet Asset Value and Publication of Monthly Report
12th Dec 201812:30 pmRNSResults of Extraordinary General Meeting
27th Nov 20184:16 pmRNSHolding(s) in Company
26th Nov 201811:00 amRNSQ3 2018 Report
23rd Nov 20181:05 pmRNSPosting of Circular and Publication of Prospectus
21st Nov 20187:00 amRNSNet Asset Value and Publication of Monthly Report
19th Oct 20187:00 amRNSNet Asset Value and Publication of Monthly Report
18th Oct 20184:45 pmRNSDividend Declaration
8th Oct 201810:06 amRNSHolding(s) in Company
21st Sep 20187:00 amRNSNet Asset Value and Publication of Monthly Report
20th Sep 20183:33 pmRNSHalf-year Report
28th Aug 20187:00 amRNSCarador Income Fund Plc Rollover Offer Proposal
24th Aug 20187:00 amRNSQ2 2018 Report
22nd Aug 20187:00 amRNSNet Asset Value and Publication of Monthly Report
20th Jul 20187:00 amRNSNet Asset Value and Publication of Monthly Report
19th Jul 20184:09 pmRNSDividend Declaration
26th Jun 20181:44 pmRNSDirector/PDMR Shareholding
22nd Jun 20181:16 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.